Quest Diagnostics (DGX) Revenue — Quarter Ended Sep 30, 2024
Revenue for the quarter increased compared with both the preceding quarter and the same quarter one year earlier. The company's trailing twelve-month revenue also showed growth.
Key takeaway
Quarter ended Sep 30, 2024 · FY2024 Q3
Revenue for the quarter increased compared with both the preceding quarter and the same quarter one year earlier. The company's trailing twelve-month revenue also showed growth.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.5B
Revenue reported for this quarter.
Quarter-over-quarter
+3.8%
Change from the immediately preceding quarter.
Year-over-year
+8.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$9.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2023 | $2.3B | -1.9% |
| Mar 31, 2024 | $2.4B | +1.5% |
| Jun 30, 2024 | $2.4B | +2.5% |
| Sep 30, 2024 | $2.5B | +8.4% |
Revenue performance
The reported revenue rose from the immediately preceding quarter, continuing a pattern of sequential increases seen in recent quarters.
Quarterly comparison
Compared with the same quarter one year earlier, revenue was higher, reflecting an expansion over the prior year period.
What to watch
Legal proceedings, as referenced in the filing, remain a factor to monitor for potential impact on future results.